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Background: Challenges remain to find ways to support patients with depression who have low levels of physical
activity (PA) to overcome perceived barriers and enhance the perceived value of PA for preventing future relapse.
There is an evidence-base for behavioural activation (BA) for depression, which focuses on supporting patients to
restore activities that have been avoided, but practitioners have no specific training in promoting PA. We aimed to
design and evaluate an integrated BA and PA (BAcPAc) practitioner-led, written, self-help intervention to enhance
both physical and mental health.
Methods/design: This study is informed by the Medical Research Council Complex Intervention Framework and
describes a protocol for a pilot phase II randomised controlled trial (RCT) to test the feasibility and acceptability of
the trial methods to inform a definitive phase III RCT. Following development of the augmented written self-help
intervention (BAcPAc) incorporating behavioural activation with physical activity promotion, depressed adults are
randomised to receive up to 12 sessions over a maximum of 4 months of either BAcPAc or behavioural activation
alone within a written self-help format, which represents treatment as usual. The study is located within two
‘Improving Access to Psychological Therapies’ services in South West England, with both written self-help interventions
supported by mental health paraprofessionals. Measures assessed at 4, 9, and 12 month follow-up include the
following: CIS-R, PHQ-9, accelerometer recorded (4 months only) and self-reported PA, body mass index, blood
pressure, Insomnia Severity Index, quality of life, and health and social care service use. Process evaluation will
include analysis of recorded support sessions and patient and practitioner interviews. At the time of writing the
study has recruited 60 patients.
Discussion: The feasibility outcomes will inform a definitive RCT to assess the clinical and cost-effectiveness of the
augmented BAcPAc written self-help intervention to reduce depression and depressive relapse, and bring about
improvements across a range of physical health outcomes.
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By 2020, depression is expected to become the second
largest burden of disease globally [1], with up to one
third of all depressed patients having episodes that last
longer than 2 years [2]. Whilst evidence-based psycho-
logical therapies for depression exist [3], unfortunately,
some three quarters of those successfully treated for
depression will relapse, having at least one further
depressive episode [2]. Depression and anxiety are
estimated to cost the UK economy £17 billion in lost
output and direct health care costs annually, with a £9
billion impact on benefit payments and lost tax receipts
[4]. However, the potential costs of depression may be
far higher since depression is associated with sustained
physical inactivity [5,6] and consequently an increased
risk of physical health co-morbidities such as obesity
[7,8], diabetes [9], and stroke [10].
Links between depression and physical health [11], and
the additional benefits of physical activity (PA) for depres-
sion beyond those provided by medication or therapy
alone are well established [12]. However, health care
services continue to reflect a ‘dualist’ philosophy [13],
targeting mental and physical health separately. In a
systematic review [14] examining the effectiveness of psy-
chological therapies for treating depression, none of 204
trials reported a measure of PA, at baseline or follow-up.
Therefore, little is known about the impact that changes
in PA have upon improved mood. Whilst a small number
of studies have sought to compare psychological interven-
tions with exercise interventions [15,16], there have been
few attempts to integrate PA into evidence-based psycho-
logical therapies for depression.
Behavioural activation (BA) potentially represents a key
psychological intervention that is capable of being adapted
to additionally target physical health outcomes alongside
depression. Adopting a systematic and graded approach,
BA targets the inertia and behavioural avoidance that
often accompany depression. This helps to overcome
sources of negative reinforcement that have maintained
avoidance whilst exposing the patient once again to sources
of positive reinforcement existent within the environment
[17]. Whereas different BA models exist, they share
a common theoretical underpinning based upon a be-
havioural model of depression [18].
Results from several systematic reviews [19] have estab-
lished BA as an evidence-based treatment for depression
[3]. Equal effectiveness for the treatment of depressionwhen compared with other psychological interventions,
including the package of interventions delivered within
cognitive behavioural therapy (CBT) have been reported
[19,20]. There have also been proposals to deliver BA for
mild-to-moderate depression within a written self-help
format [17,19]. This BA format features prominently as a
key low-intensity CBT intervention within the Improving
Access to Psychological Therapies (IAPT) programme,
implemented across England [21,22].
Whilst aiming to increase behaviour, the focus of BA
is, however, not conventional upon systematically increas-
ing PA in a manner that could improve physical health
outcomes by adopting techniques associated with PA pro-
motion [23]. However, a focus upon improving physical
health outcomes within BA may be achieved with only a
slight shift in emphasis. For example, following an initial
focus upon improving mood, at an opportune moment,
the emphasis could be widened to also target physical
health outcomes by selectively reinforcing activities that
require greater energy expenditure. This shift in emphasis
could potentially be facilitated by the augmentation of BA
with a model of health behaviour change, such as self-
determination theory [24], to help develop behavioural
self-regulatory skills.
PA, in the form of exercise, is an evidence-based inter-
vention for depression in its own right [25] and has add-
itional physical health benefits that medication and
psychotherapy treatments do not provide when used inde-
pendently. However, evidence comes from trials involving
participants who may be more motivated to do structured
exercise sessions, with intensive support. With techno-
logical advances, such as accelerometers to capture PA,
there is increasing interest in focusing interventions on
breaking up sedentary time and increasing overall daily
PA to enhance both physical and mental health [26,27].
Such interventions may also have a greater appeal to pa-
tients with depression when compared with those involv-
ing recommendations for types of structured exercises [3].
Augmenting BA with approaches to facilitate PA could
therefore potentially broaden the effectiveness of the inter-
vention when compared to BA alone, and represents an
opportunity to address both mental and physical health
outcomes. Both BA and PA promotion also seem highly
compatible in approach, employing techniques such as
self-monitoring, goal setting, and problem solving. All of
these techniques have been independently shown to be
effective behavioural change strategies [28].
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overcome limitations associated with the use of each
intervention when used independently. In particular, the
combined intervention may help to reduce the rate of
depressive relapse that can occur following treatment.
For example, following BA alone, up to two thirds of
patients recovering from one episode of depression will
relapse and have at least one further episode within
12 months [29]. Previous research examining the benefits
of PA for depression raise the possibility that augmenting
BA with PA promotion may help to reduce depressive re-
lapse and maintain the therapeutic gains arising from the
initial use of BA. For example, following successful treat-
ment for depression, relapse rate 6 months post-treatment
was 38% following initial treatment with medication alone,
reducing to 31% with medication combined with PA and
reduced further to 8% with PA alone [30].Study aims and objectives
Informed by the new Medical Research Council (MRC)
framework for the development of complex interventions
[31], the protocol for a phase II pilot randomised con-
trolled trial (RCT) is reported. This study will examine a
number of methodological uncertainties to inform the
conduct of a phase III RCT to assess the clinical and cost-
effectiveness of a combined BA and PA promotion inter-
vention (BAcPAc) to reduce depressive relapse and
improve physical health outcomes for adults with depres-
sion compared to BA alone, which represents treatment as
usual. No prospectively-identified criteria for progression
to a main trial have been set.
This pilot RCT does not involve any hypothesis testing
and therefore there is no primary outcome. We are inter-
ested to test recruitment and retention rates as well as
gain qualitative feedback on feasibility and acceptability of
the methodology. The specific feasibility outcomes with
the method of evaluation for this pilot RCT are shown in
Table 1.Table 1 Feasibility outcomes and evaluation
Feasibility outcomes Ev
1. Feasibility of participant recruitment N
re
2. Appropriateness of data collection processes and outcome measures N
3. Participant understanding of study information Q
4. Estimation of sample size to inform a phase III RCT D
th
5. Level of study attrition St
6. Estimate of the resources and costs needed to deliver the
intervention
Va
pr
7. Acceptability towards the cognitive behavioural therapy self-help
intervention received, and engagement with the BAcPAc intervention
Q
paMethods
This protocol is informed by SPIRIT [33] guidance for
the reporting of protocols of clinical trials (Additional
file 1).
Study design
This study employs a single (researcher) blind, parallel-
randomised controlled trial design with nested mixed
methods process evaluation. Subjects are randomised
individually in a 1:1 ratio to either a written self-help inter-
vention based upon BA combined with PA promotion
(BAcPAc) or a written self-help intervention based upon
BA alone, representing treatment as usual (TAU) (Figure 1)
[34].
Participants are being recruited through two IAPT
services [21] located in one rural (East and Mid Devon)
and one city based location (Plymouth). Both services are
located in the county of Devon, South West of England.
Participant inclusion criteria
Eligible participants are aged 18 and over, with a current
episode of depression confirmed using the structured diag-
nostic Clinical Interview Schedule (CIS-R) [32] and score
between 10 and 23 on the Participant Health Questionnaire
(PHQ-9) [35] reflecting moderate to moderately-severe de-
pression. Additionally, eligible participants are required to
confirm that they can walk continuously and unaided for
5 minutes. Reflecting standard clinical practice, participants
are eligible to participate in the study regardless of whether
they are currently receiving antidepressant medication, as
long as the dose has been stable for at least 28 days prior
to recruitment into the study.
Participant exclusion criteria
Potential participants are excluded from the study if they
are currently receiving formal psychotherapy for their
depression, been diagnosed with a severe and enduring
mental health problem, are currently doing at least 30
continuous minutes of moderate intensity physicalaluation
umbers assessed for eligibility, numbers eligible, reasons for ineligibility,
asons for non-participation, and numbers randomised
umber of missing items and follow-up rates
ualitative process interviews with participants following participation
ifferences at follow-up between study arms in the number of participants
at reach an ICD-10 diagnosis of depression using the CIS-R [32]
udy and treatment drop-out rates
riability in the number, length, and frequency of support sessions
ovided by psychological wellbeing practitioners
ualitative process interviews undertaken with participants following
rticipation
Figure 1 Consort diagram.
Farrand et al. Trials 2014, 15:196 Page 4 of 12
http://www.trialsjournal.com/content/15/1/196activity on 5 or more days of the week, score 2/3 on the
PHQ-9 [35] suicide risk question, have been prescribed
an antidepressant in the month prior to recruitment,
have current substance or alcohol addiction, are unable
to use written self-help materials in English, or are cur-
rently involved in another research study that would
make participation difficult.
Recruitment settings and procedure
Different recruitment strategies have been adopted for
the two IAPT services participating in the study to allow
comparison of different participant recruitment strat-
egies. In Plymouth, potential participants meeting the
inclusion criteria are invited to participate in the study at
the end of the initial assessment session by being handeda study invitation pack by their psychological wellbeing
practitioner (PWP) undertaking the assessment. In East
and Mid Devon, the study invitation pack is posted to all
potential participants who have self-referred or have been
referred by a health professional into the IAPT service. In
both cases, the invitation packs include a study invitation
letter, study information sheet, and consent form.
Screening, baseline, and informed consent
Potential participants willing to consider participation
are asked to contact the researcher directly by phone or
mailing the consent form (Additional file 2) with their
contact details. Any further questions about the trial are
answered on the phone and, if participants wish to par-
ticipate, they are asked to provide verbal consent for a
Farrand et al. Trials 2014, 15:196 Page 5 of 12
http://www.trialsjournal.com/content/15/1/196telephone screening informed by the inclusion criteria to
assess eligibility for study inclusion. Following screening,
and after gaining written consent, eligible participants
are invited to attend a full baseline appointment with
the researcher using the CIS-R [32] to confirm a diagno-
sis of major depression with participant randomisation
undertaken following baseline assessment.
Confidentiality
All personal data held electronically is stored on a pass-
word protected computer at the University of Exeter.
Personal data held on paper files are locked in a filing
cabinet at the University of Exeter, with the researcher
being the only person with access to the key. All the in-
formation will be safely stored in line with the principles
of the Data Protection Act. PWPs operating within the
respective IAPT Services will follow guidance for Good
Clinical Practice. Consistent with good clinical practice
and detailed in the consent form, significant suicidal risk
identified will be discussed with the participant and the
GP will be informed. The consent form will also let the
person know that, if we are very concerned about their
safety or someone else’s safety, we would need to break
confidentiality.
Randomisation
A web-based minimisation service supported by the
Peninsula Clinical Trials Unit ensures concealment al-
location of participants to a PWP who has either been
trained to deliver BA as usual or BAcPAc. To preserve
researcher blinding regarding the study arm participants
are randomised into, the Peninsula Clinical Trials Unit
sends an e-mail containing randomisation details for the
participant to the IAPT service administrator and a PWP
supporting the intervention within that service. At the
same time, the participant’s ID number with no other per-
sonal information is also e-mailed to the researcher.
Minimisation is based on the following prognostic fac-
tors: participant age (10–30 years or >31years), sex (male
or female), PHQ-9 [35] score (moderate/moderately-severe
10–18; moderately-severe/severe 19–23), current use of
anti-depressant medication (yes or no), and recruitment
site (Plymouth or East and Mid Devon). To maintain con-
cealment, the minimisation algorithm retains a stochas-
tic element, providing a degree of unpredictability
during the allocation process. The first participant was
randomised on the 23rd of April 2013.
Sample size
A total of 80 participants (40 participants per arm) will
be recruited. This sample size has been informed by the
recommended sample size of ~30 participants per arm for
estimation of outcome variance [36] and takes into ac-
count a 20% attrition rate over the duration of the study.Treatments
For both the BAcPAc (intervention) and BA alone
(TAU) study arms, the BA protocol was developed by
Richards [17] and represents the protocol implemented
as part of the IAPT programme [21,22]. In the BA alone
study arm, the BA protocol [17] has been directly trans-
ferred into a written self-help format specifically devel-
oped and adopted for use within the study (available on
request from the authors). The patient works through
the written self-help intervention with a maximum of 12
support sessions provided by a PWP [37]. In the BAcPAc
study arm, the BA protocol [17] formed the foundation
of an extensive development process based upon focus
groups and informed by intervention mapping tech-
niques [17] to deconstruct the BA protocol, and then to
reconstruct it within a written self-help intervention
[37] incorporating additional PA promotion techniques
(available on request from the authors).
Interventions are delivered by four PWPs in both
recruitment sites, with two randomised to deliver the
BAcPAc study arm and two BA alone in both sites. The
PWP role was developed as part of the IAPT programme
to support low-intensity CBT interventions within a
stepped care model of service delivery for patients pre-
senting with depression and anxiety disorders (excluding
PTSD and social anxiety) of mild-to-moderate severity
[37]. All PWPs involved in the study have successfully
completed an accredited PWP training programme
based upon the curriculum [38] developed for the IAPT
programme.
Furthermore, study PWPs also received an additional
one-day training session delivered by members of the
research team. The training introduced the PWPs to the
study and provided them with the opportunity to
address any questions. Additionally, procedures for work-
ing within the trial, including recording sessions and
maintaining records on patient contacts, were reviewed.
The training additionally overviewed the self-help inter-
vention and theoretical rationale, appropriate to the study
arm they were randomised to support. For PWPs in both
study arms training used role-play to enhance skill devel-
opment in supporting the appropriate self-help interven-
tion. For PWPs supporting the BAcPAc intervention this
also included skills enhancement in PA promotion tech-
niques (Figure 1), included within the self-help interven-
tion. Training sessions also provided the opportunity to
ask any questions concerning the intervention protocols.
PWPs supporting BAcPAc (Additional file 3) and BA
alone (Additional file 4) are given a training manual to
supplement the training received. During the course of
the study, PWP supervision was conducted in accordance
with IAPT supervision guidance [39]. Supervisors in the
BAcPAc arm have also been provided with the BAcPAc
intervention and encouraged to contact a member of the
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tion or to raise questions emerging from the supervision
sessions.
As with any pragmatic study, interventions in both
study arms are delivered in accordance with the IAPT
service delivery protocol developed to inform the deliv-
ery of low-intensity CBT interventions, including CBT
self-help [37]. Consistent with this protocol, the number
and length of support sessions in both study arms is not
specified in advance, but determined collaboratively be-
tween the PWP and patient on the basis of any change
in the patient’s depressive symptoms. Alternatively, par-
ticipants are free to stop treatment or withdraw from
the study at any time. In the case of a participant dis-
closing immediate suicidal risk to a PWP or researcher,
the risk protocol will be followed and the participant will
be withdrawn from the study.
Typically, participants receive one assessment session
of up to 35 minutes followed by up to 12 support
sessions of 25–35 minutes [37], with an average of 5.5
used within the IAPT programme [22]. The assessment
session largely comprises a client-centred assessment to
understand the difficulties experienced by the participant,
administration of questionnaires to measure severity of
depression, anxiety, and impact of mental health difficulty
on work and social adjustment, alongside the provision of
information concerning the wider impact of depression.
Additionally, during the assessment session, participants
are introduced to the written CBT self-help intervention
related to the study arm they have been randomised into.
Participants in the BAcPAc arm are given the BAcPAc
written self-help intervention [40], whilst those in the BA
alone arm are given the BA written self-help intervention
[41]. Participants in both study arms are also given written
gender-specific case studies that introduce the BAcPAc or
BA alone intervention.
Subsequent support sessions are based around identi-
fying the participant’s progress on the use of the spe-
cific written CBT self-help intervention developed for
their study arm and provide guidance and encourage-
ment to support the participants’ continued usage of
the written self-help intervention. In the event the
participant struggles with any activity detailed in the
written CBT self-help intervention, the PWP reviews
the intervention with the participant to enable him/her
to problem-solve the difficulty and provide motivation
to enable them to move forward with the intervention
before the next support session. Dependent upon par-
ticipants’ preference, support is provided face-to-face,
over the phone, or through a combination of both
methods. Furthermore, if requested, face-to-face sessions
take place in a variety of locations including the partici-
pating IAPT service or GP surgery attached to the IAPT
service.Control arm
Representing treatment as usual, the intervention is de-
livered in accordance with the BA protocol [17], the
IAPT service delivery protocol [37], accredited training
received during their PWP training programme [38],
and the one day training delivered by the research team
to introduce the intervention and case studies in the
written self-help format developed for the study.
Intervention arm
The written BAcPAc self-help intervention is identical to
the self-help intervention used in the control arm with
the exception of the following adaptations made to in-
clude targeted PA promotion elements (Figure 2).
i) The rationale for the intervention is altered to
emphasise and reinforce the added value of activities
that include a PA component.
ii) Principles derived from self-determination theory
[24,26] are used to inform the development of the
BAcPAc self-help intervention. In particular, this was
used to adapt the text and content of the support
provided by the PWP to help motivate and engage
participants to maintain and develop plans to initiate
more activities that involve sustainable PA into their
normal weekly planning.
iii) If the PWP identifies participant mood starting to
improve during treatment he/she encourages the
participant to further increase PA using principles
informed by self-determination theory [24] alongside
techniques derived from motivational interviewing
[42]. This helps maintain participant motivation to
continue with the PA identified as part of the
standard BA aspect of the intervention.
iv) The diary keeping elements of the BAcPAc self-help
intervention were adapted to specifically prompt
the participant to continue to monitor and plan
their PA using the worksheets included within the
intervention.
v) On occasions when the participant has planned PA
involving walking within their diary, the PWP
encourages the participant to use a pedometer [43]
and record the number of steps taken per day on
the appropriate worksheets included within the
BAcPAc self-help intervention.
vi) Finally, unlike participants in the control arm, those
randomised to the BAcPAc arm receive a 10–15
minute follow-up phone call by the PWP one
month after the end of treatment at a time agreed
between the PWP and participant during the last
support session. The aim of this appointment is
to review progress with the BAcPAc self-help
intervention and support the participant to continue
with PA by encouraging them to continue to
Figure 2 Intervention processes.
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problem-solve any difficulties, and resume the
BAcPAc self-help intervention and case studies if
they identify any worsening of mood.
Blinding
Participants and research staff conducting assessments
are kept blind to study arm allocation as far as possible.
Throughout duration of the trial, participants are
reminded not to disclose the study arm they have been
randomised to during contact with the researcher. A
member of the research team collects research data,
with blinding concerning participant study arm alloca-
tion maintained as far as possible. A researcher (CP)
checks all data for accuracy before conversion to elec-
tronic format using TeleForm software (www.cardiff-
teleform.com). Cardiff TeleForm is programmed to
perform a range checks for numerical data and to
inspect every data entry point is present. All data
collected from participants will be assigned a unique
ID number and kept separate to any patient identifi-
able data. All data is kept in lockable cabinets at theUniversity of Exeter, and is not shared with anyone
outside the research team. Statistical analyses are
undertaken by a member of the research team (FW)
blinded to study arm allocation. Instances that arise
regarding accidental disclosure of allocation are re-
corded by the unblinded research team member.
Outcome measurement
Feasibility outcomes
The feasibility outcomes are related to the aims associ-
ated with a pilot RCT [44]. Descriptive comparisons
across the primary outcome measures of interest will
be made between the two recruitment sites adopting
different recruitment techniques. The feasibility out-
comes are outlined in Table 1.
Assessments
To inform inclusion within a definitive phase III RCT,
data on the following assessments will be collected.
i. Diagnosis of depression: ICD-10 diagnosis as a
binary (yes or no) outcome by the CIS-R [32].
ii. Symptoms of depression and index of depressive
relapse: PHQ-9 [35] based upon an adapted
protocol [45].
iii. PA sedentary behaviour and total energy expenditure:
assessed using an accelerometer (GENEActiv) worn on
the wrist for one week and a 7-day PA recall survey [46].
iv. The Insomnia Severity Index (ISI) [47].
v. Health-related quality of life: Short Form-36 (SF-36
[48]) and EuroQol (EQ-5DL [49]).
vi. Health and social care services use and cost:
simplified version of the Adult Service Use Schedule
(ADSUS [50]).
vii. Blood pressure: the average of the last two from
three measurements taken seated from the left arm
following 10 minutes of rest measured using an
Omron M7 Monitor.
viii. Body mass index: weight measured using Omron
HN286 Digital Scales and height measured using a
tape measure.
In addition, general demographic information, includ-
ing gender, age, ethnicity, marital status, smoking status,
postcode, number of dependants, and age of leaving
education, is collected from all participants at baseline.
Data collection
The researcher collects general demographic informa-
tion during telephone screening. All other data inform-
ing the feasibility outcomes is extracted from routine
service records by the PWP delivering the intervention
at the end of the support session, by the researcher
during 4-, 9-, and 12-month follow-up, or from process
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deviation from planned treatment. Time points repre-
senting collection of the assessments are highlighted in
Table 2.
Assessments taken at baseline are collected face-to-
face or over the telephone depending upon patient pref-
erence, with height, weight, and blood pressure collected
face-to-face. All data collected at 4-month follow-up is
collected face-to-face, with 9 and 12 month follow-up
data collected face-to-face or over the phone, depending
on patient preference. Adverse events are reported by
PWPs to the researcher during routine communication
and spontaneously. The researcher inquires of any ad-
verse events at follow-up. Any events are recorded and
escalated to the PI, and if necessary, to the sponsor.
Process evaluation
The aims of the process evaluation are to assess or iden-
tify: i) the acceptability of the BAcPAc intervention for
patients and PWPs, ii) the fidelity of delivery of the
BAcPAc intervention (how well does delivery match our
intentions), iii) additional training needs for PWPs de-
livering the interventions, iv) any future adaptations
needed in the BAcPAc intervention. Data gathered as
part of the process evaluation will be used to further
adapt the BAcPAc written self-help intervention and
training in preparation for the phase III RCT. Qualita-
tive interviews are conducted with participants rando-
mised to the BAcPAc study arm and with PWPs
supporting the interventions.
Qualitative interviews
After the final support session, all participants receiving
the BAcPAc intervention are invited to participate in a
semi-structured interview. This examines intervention
acceptability and identifies adaptations that participantsTable 2 Assessments administered at screening, baseline, and
Screening Baseline 4 month
PHQ-9 X
CIS-R X
Physical activity
7 day PA recall X
Accelerometer
Body mass index X
Blood pressure X
Health and social care service use (ADSUS) X
Sleep-insomnia severity index X
Quality of life
SF-36 X
EQ-5D Xfeel may improve the assessment or support provided
for the BAcPAc intervention. Interviews follow a pre-
determined interview schedule, with the topic guide
(Additional file 5) partially informed by a previous qualita-
tive study investigating acceptability of CBT self-help for
the treatment of depression in patients with chronic phys-
ical illness [51]. This was developed in consultation with
the intervention development team and a patient and pub-
lic involvement group specifically established to support
the study. Interviews are digitally recorded and transcribed
verbatim. Data is analysed using framework analysis
[52] alongside constant comparison techniques [53] to
generate concepts and themes. To ensure rigour, the
researcher reads transcripts and develops the initial cat-
egorisation, with second coding undertaken by another
member of the research team. Further categorisations
are discussed amongst the team and amendments to
categories and definitions made as required [54]. Qua-
litative data is analysed using ‘surface level’ thematic
analysis only. This involves coding the data to extract
concepts and grouping the concepts together into
themes.
Intervention fidelity checking
All support sessions (face-to-face or telephone) in both
study arms are digitally recorded. A 20% sample is then
assessed to review intervention fidelity for each PWP
using an intervention fidelity measure. Recordings are
listened to by a member of the research team, who
applies the intervention fidelity measure to rate com-
petence in each element of the intervention. Based on
previously used intervention fidelity measures [26,55]
and informed by a prior intervention mapping pro-
cedure [56], a version specifically developed for the
BAcPAc intervention (Additional file 6) was adopted.
The measure incorporates the Dreyfus skill acquisitionfollow-up post-baseline
s post baseline 9 months post baseline 12 months post baseline
X X X
X X
X
X X
X X
X X
X X
X X
X X
X X
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ering the targeted techniques and delivery processes.
The scale produces a score of 0 to 6 for each targeted
element of the intervention process and is anchored so
that a score of 3 is considered acceptable, 0 is non-
existent, and 6 is perfect performance. Intervention fidelity
measure scores are summarised using simple descriptive
statistics (means and standard deviations) and collated
both in total and by therapist. Examples of good practice
are flagged, transcribed, and extracted as audio clips or
text transcripts to inform future training. Items scoring
low for some or all PWPs supporting the intervention are
used to identify areas where change is needed to the inter-
vention materials or PWP training course.
Statistical analysis
Quantitative
For both recruitment settings, participant flow will be
summarised using the CONSORT flow diagram adapted
for complex interventions [58], reporting recruitment
and attrition rates (both treatment and study drop-outs)
with 95% confidence intervals. The CONSORT flow
diagram will also be adapted to reflect the number of
recruitment letters sent, numbers consenting, number
randomised, number undertaking intervention, and
number of completed outcomes alongside means, stand-
ard deviations and frequencies regarding the number of
support sessions, session length, and mean number of
days between support sessions. All protocol deviations,
along with number of missing items on questionnaires,
will be reported. Mean and standard deviations for
general demographic information will be reported at
baseline with assessments conducted at baseline and
4-, 9-, and 12-month follow-up.
Economic analysis
Factors related to collecting self-reported data on partici-
pant NHS and related resource use will be examined. In-
formed by case report forms, methods for estimating the
resource use and costs associated with delivery of the
intervention will be developed and tested. Whilst it is not
possible to estimate cost-effectiveness in this pilot study,
estimates of intervention cost will inform exploratory
modelling and estimates of the resources and costs needed
to run a future trial. In a future phase III RCT, cost-
effectiveness analysis is expected to involve both within-
trial analysis and evidence synthesis with decision-analytic
modelling, to assess the longer-term consequences of the
intervention (e.g., changes in outcomes, events avoided,
life-years, and quality-adjusted life-years gained). It is ex-
pected that this modelling will use/adapt existing eco-
nomic models on outcomes for depression and PA
promotion, and the subsequent cost-effectiveness of inter-
ventions. This study will be used to conduct preliminaryinvestigations on how best to construct such analyses and
develop an economic evaluation plan for the planned
phase III RCT. A summary of the results will be available
to participants who have requested this during consent,
and a report provided to the participating IAPT services.
The findings will be reported in a number of peer
reviewed journals.
Ethical approval
This protocol has been reviewed and approved (26/03/
2013) by the NHS South West Regional Ethics Committee
(REC reference number: REC/SW/0291).
Changes to methods since recruitment began
Since trial recruitment began in April 8th 2013, the
following important changes have been made:
1) A small number of potential participants from Mid
and East Devon had reported that they would
experience difficulties taking part in the study if they
could not be seen at a convenient location.
Originally, PWPs were only seeing participants in
one location. We therefore extended the number of
locations where patients could be seen for treatment
and, as the service routinely offer face-to-face or
phone appointments to patients, we also changed
the information sheet to emphasise that participants
entering the study could be treated either face-to-face
or over the phone. (Approved 15/08/2013)
2) Participants often have had their prescription
changed by their GP at the same time as referral to
the service, and so we were excluding many
potential participants. This has been considered
useful for previous trials to establish stability in
mood prior collecting baseline measures, but is not
a clinical requirement. Given a high rate of
exclusion from this study, we are now recording if
participants have changed or been prescribed an
antidepressant in the last month, and are collecting
information about current and past medication from
all participants at baseline and follow-up. We have
therefore removed the exclusion criteria “changed or
newly prescribed antidepressant in the previous
month”. (Approved 15/08/13)
Discussion
This phase II pilot RCT has been designed to answer
important methodological uncertainties, the answers to
which can be used to inform the design and implemen-
tation of a planned phase III RCT. Undertaking prag-
matic trials in natural settings are notoriously complex
and require careful testing to determine the acceptability
and effectiveness of the trial methods, including those
associated with the intervention. The need for this phase
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to locate the planned phase III RCT within IAPT
services with the intervention delivered by a para-
professional PWP workforce. To date, both the setting
and workforce have been employed within few RCTs [59].
Furthermore, given the novel basis of the written
BAcPAc self-help intervention, this study also includes
a planned process evaluation and assessment of inter-
vention fidelity to provide valuable information on how
to refine the written BA self-help intervention to include
PA promotion techniques. When best to emphasise these
techniques within the support protocol following improve-
ments in mood associated with an initial emphasis upon
BA will also be addressed. There is currently no informa-
tion on whether patients who receive BA spontaneously
become more physically active and the data collected in
this study will help to inform the extent that any adapted
BAcPAc intervention would need to increase PA in order
to have any impact on physical and mental health out-
comes in a definitive trial.
Combining BA with PA within the BAcPAc written
self-help intervention offers the potential to increase
time to depressive relapse, provide patients an add-
itional method to manage their depression, and lead to
physiological health benefits resulting in reduced risk
for physical health co-morbidities. Development and
evaluation of such an intervention is timely given pro-
posals to expand the competencies associated with the
PWP role to include an increased emphasis upon phys-
ical health [60]. If effective, such an intervention also
provides the potential to target mental and physical
health outcomes within a single intervention and fur-
ther increase access to evidence-based psychological
therapies [21,22].
Trial status
The recruitment phase of this study started in April,
2013 and has an intended completion date for recruit-
ment of April, 2014.
Access to data
The full cleaned dataset will be held by Dr Paul Farrand
at the University of Exeter. All investigators will have full
access to the data after a formal request describing their
plans is approved by the steering group.
Additional files
Additional file 1: SPIRIT checklist.
Additional file 2: Study consent form.
Additional file 3: PWP training manual BAcPAc.
Additional file 4: PWP training manual BA.
Additional file 5: Participant topic guide.Additional file 6: BAcPAc intervention fidelity measure.
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